155 related articles for article (PubMed ID: 1801054)
1. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
Brumfitt W; Hamilton-Miller JM; Smith GW; al-Wali W
Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
[TBL] [Abstract][Full Text] [Related]
2. Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin.
Brumfitt W; Hamilton-Miller JM; Walker S; Roberts D
Drugs Exp Clin Res; 1992; 18(6):239-44. PubMed ID: 1478163
[TBL] [Abstract][Full Text] [Related]
3. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection.
Brumfitt W; Hamilton-Miller JM
Infection; 1995; 23(2):98-102. PubMed ID: 7622272
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.
Brumfitt W; Hamilton-Miller JM
J Antimicrob Chemother; 1998 Sep; 42(3):363-71. PubMed ID: 9786476
[TBL] [Abstract][Full Text] [Related]
5. Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection.
Raz R; Boger S
Antimicrob Agents Chemother; 1991 Jun; 35(6):1241-2. PubMed ID: 1929272
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.
Stamey TA; Condy M; Mihara G
N Engl J Med; 1977 Apr; 296(14):780-3. PubMed ID: 320482
[TBL] [Abstract][Full Text] [Related]
7. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.
Mavromanolakis E; Maraki S; Samonis G; Tselentis Y; Cranidis A
J Chemother; 1997 Jun; 9(3):203-7. PubMed ID: 9210003
[TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin].
Lettgen B; Tröster K
Klin Padiatr; 2002; 214(6):353-8. PubMed ID: 12424684
[TBL] [Abstract][Full Text] [Related]
9. The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience.
Alexiou Z; Mouktaroudi M; Koratzanis G; Papadopoulos A; Kavatha D; Kanellakopoulou K; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2007 Jul; 30(1):40-3. PubMed ID: 17459663
[TBL] [Abstract][Full Text] [Related]
10. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
[TBL] [Abstract][Full Text] [Related]
11. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
Price JR; Guran LA; Gregory WT; McDonagh MS
Am J Obstet Gynecol; 2016 Nov; 215(5):548-560. PubMed ID: 27457111
[TBL] [Abstract][Full Text] [Related]
12. A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections.
Brumfitt W; Smith GW; Hamilton-Miller JM; Gargan RA
J Antimicrob Chemother; 1985 Jul; 16(1):111-20. PubMed ID: 4044461
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
Schaeffer AJ; Stuppy BA
J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399
[TBL] [Abstract][Full Text] [Related]
14. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
16. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.
Melekos MD; Asbach HW; Gerharz E; Zarakovitis IE; Weingaertner K; Naber KG
J Urol; 1997 Mar; 157(3):935-9. PubMed ID: 9072603
[TBL] [Abstract][Full Text] [Related]
17. A double-blind controlled trial of norfloxacin versus cotrimoxazole in the treatment of urinary tract infections.
Chan MK; Wong WT; Cheng IK
Br J Clin Pract; 1989 Feb; 43(2):61-3. PubMed ID: 2679836
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin treatment in complicated urinary tract infection.
Boerema JB; van Saene HK
Scand J Infect Dis Suppl; 1986; 48():20-6. PubMed ID: 3465030
[TBL] [Abstract][Full Text] [Related]
19. Review of norfloxacin in complicated and recurrent urinary tract infections.
Schaeffer AJ
Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
[TBL] [Abstract][Full Text] [Related]
20. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
Boerema JB; Olthof BJ; van Saene HK
Scand J Infect Dis Suppl; 1986; 48():27-31. PubMed ID: 3095916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
